Private Advisory Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $290K | Sell |
1,563
-315
| -17% | -$58.5K | 0.03% | 176 |
|
|
2025
Q1 | $393K | Sell |
1,878
-70
| -4% | -$14.7K | 0.04% | 148 |
|
|
2024
Q4 | $346K | Buy |
1,948
+610
| +46% | +$108K | 0.04% | 163 |
|
|
2024
Q3 | $264K | Sell |
1,338
-54
| -4% | -$10.7K | 0.03% | 173 |
|
|
2024
Q2 | $239K | Sell |
1,392
-312
| -18% | -$53.5K | 0.03% | 159 |
|
|
2024
Q1 | $310K | Buy |
+1,704
| New | +$310K | 0.04% | 156 |
|
|
2023
Q1 | – | Sell |
-1,260
| Closed | -$204K | – | 198 |
|
|
2022
Q4 | $204K | Buy |
+1,260
| New | +$204K | 0.04% | 185 |
|
|
2022
Q3 | – | Sell |
-1,721
| Closed | -$264K | – | 179 |
|
|
2022
Q2 | $264K | Buy |
+1,721
| New | +$264K | 0.06% | 138 |
|
|
2018
Q1 | – | Sell |
-3,825
| Closed | -$370K | – | 101 |
|
|
2017
Q4 | $370K | Buy |
+3,825
| New | +$370K | 0.2% | 98 |
|